{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:22:37Z","timestamp":1756311757378,"version":"3.41.2"},"reference-count":64,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T00:00:00Z","timestamp":1740873600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Science Reports"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background and Aims<\/jats:title><jats:p>Accurate and transparent investigation of adverse events (AEs) following COVID\u201019 vaccination enhances social trust and confidence in vaccination programs. This study aimed to assess the prevalence of COVID\u201019 vaccination\u2010related AEs among medical sciences students.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this cross\u2010sectional study, a self\u2010administered survey via Google Forms was conducted to evaluate AEs associated with the AZD1222 (Oxford\u2010AstraZeneca) and BBIBP\u2010CorV (Sinopharm) vaccines among medical sciences students. Data were collected following participation in a training program focused on the symptomatology of AEs, which was designed to reduce confirmation bias.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 263 medical sciences students from North Khorasan University of Medical Sciences, Bojnurd, Iran, participated in this study, with data collection occurring from August 8 to September 1, 2021. The median age of the study population was 23 years (IQR: 22\u201324), with 207 participants being female (78.7%). Following the first dose, the prevalence of AEs was significantly more common in the Oxford\u2010AstraZeneca group compared to the Sinopharm group [OR 12.93 (5.57\u201330.03), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001]. However, in the second dose, there was no significant difference in the prevalence of AEs between the Oxford\u2010AstraZeneca group compared to the Sinopharm group [OR 1.45 (0.86\u20132.46), <jats:italic>p<\/jats:italic>\u2009=\u20090.17]. Injection site pain, fever, body\/muscle pain, headache, feeling unwell, and fatigue were the most common AEs associated with both vaccines, with variations in the prevalence between the vaccines and between doses. The type of vaccine and sex were the only factors influencing the prevalence of AEs. Notably, the odds of experiencing AEs were higher in women compared to men.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The findings of this study indicated that the prevalence of AEs was higher for the Oxford\u2010AstraZeneca vaccine compared to the Sinopharm vaccine. Further research is necessary to explore the impact of utilizing standardized definitions and common terminology for COVID\u201019 vaccination\u2010related AEs in ensuring accurate and consistent reporting.<\/jats:p><\/jats:sec>","DOI":"10.1002\/hsr2.70492","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T08:33:32Z","timestamp":1741422812000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Self\u2010Reported Adverse Events Following COVID\u201019 Vaccination Among Medical Sciences Students After a Symptomatology Training Program: A Cross\u2010Sectional Study"],"prefix":"10.1002","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8409-673X","authenticated-orcid":false,"given":"Taraneh","family":"Tavanaei Tamanaei","sequence":"first","affiliation":[{"name":"Lung Diseases Research Center Mashhad University of Medical Sciences Mashhad Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2098-613X","authenticated-orcid":false,"given":"Mohammad Bagher","family":"Oghazian","sequence":"additional","affiliation":[{"name":"Clinical Research Development Unit, Imam Hassan Hospital North Khorasan University of Medical Sciences Bojnurd Iran"},{"name":"Department of Internal Medicine, Faculty of Medicine North Khorasan University of Medical Sciences Bojnurd Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8406-1671","authenticated-orcid":false,"given":"Mehran","family":"Mojtabaee","sequence":"additional","affiliation":[{"name":"Student Research Committee North Khorasan University of Medical Sciences Bojnurd Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5193-4543","authenticated-orcid":false,"given":"Mojdeh","family":"Faregh","sequence":"additional","affiliation":[{"name":"Student Research Committee North Khorasan University of Medical Sciences Bojnurd Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5517-0259","authenticated-orcid":false,"given":"Sahar","family":"Oghazian","sequence":"additional","affiliation":[{"name":"Clinical Research Development Unit, Imam Hassan Hospital North Khorasan University of Medical Sciences Bojnurd Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6094-065X","authenticated-orcid":false,"given":"Erfan","family":"Tavana","sequence":"additional","affiliation":[{"name":"Student Research Committee North Khorasan University of Medical Sciences Bojnurd Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4982-2083","authenticated-orcid":false,"given":"Amin","family":"Hoseinzadeh","sequence":"additional","affiliation":[{"name":"Clinical Research Development Unit, Imam Hassan Hospital North Khorasan University of Medical Sciences Bojnurd Iran"},{"name":"Student Research Committee North Khorasan University of Medical Sciences Bojnurd Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8657-7980","authenticated-orcid":false,"given":"Ramin","family":"Haghighi","sequence":"additional","affiliation":[{"name":"Clinical Research Development Unit, Imam Hassan Hospital North Khorasan University of Medical Sciences Bojnurd Iran"},{"name":"Department of Urology, Faculty of Medicine North Khorasan University of Medical Sciences Bojnurd Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,3,2]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2001017"},{"key":"e_1_2_11_3_1","unstructured":"WHO \u201cDirector\u2010General's Opening Remarks at the Media Briefing on COVID\u201019 \u201d March 11 2020 https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020."},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.07.003"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/S13577-021-00512-4"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3270"},{"key":"e_1_2_11_7_1","unstructured":"\u201cWHO Issues Its First Emergency Use Validation for a COVID\u201019 Vaccine and Emphasizes Need for Equitable Global Access \u201d World Health Organization (WHO Outbreak Began a Year Ago) accessed September 1 2024 https:\/\/www.who.int\/news\/item\/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access#:~:text=The."},{"key":"e_1_2_11_8_1","unstructured":"\u201cUK Medicines Regulator Gives Approval for First UK COVID\u201019 Vaccine \u201d GOV.UK accessed September 1 2024 https:\/\/www.gov.uk\/government\/news\/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine#full-publication-update-history."},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-023-00594-y"},{"key":"e_1_2_11_10_1","unstructured":"\u201cCOVID\u201019 Vaccine Tracker and Landscape \u201d accessed September 1 2024 https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines."},{"key":"e_1_2_11_11_1","unstructured":"\u201cCOVID\u201019 Vaccine Tracker \u2013 12 Vaccines Granted Emergency Use Listing (EUL) by WHO \u201d accessed September 1 2024 https:\/\/covid19.trackvaccines.org\/agency\/who\/."},{"key":"e_1_2_11_12_1","unstructured":"\u201cThe Oxford\/AstraZeneca (ChAdOx1\u2010S [Recombinant] Vaccine) COVID\u201019 Vaccine: What You Need to Know \u201d accessed September 1 2024 https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know."},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxac031"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijpvm.ijpvm_513_21"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43168-021-00109-3"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_474_21"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27203"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10040596"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-023-09357-5"},{"key":"e_1_2_11_20_1","unstructured":"\u201cWHO Lists Additional COVID\u201019 Vaccine for Emergency Use and Issues Interim Policy Recommendations \u201d accessed September 1 2024 https:\/\/www.who.int\/news\/item\/07-05-2021-who-lists-additional-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations."},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10060920"},{"key":"e_1_2_11_22_1","unstructured":"\u201cThe Sinopharm COVID\u201019 Vaccine: What You Need to Know \u201d accessed September 1 2024 https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-sinopharm-covid-19-vaccine-what-you-need-to-know."},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.12492"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.945930"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-021-00878-5"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-021-00915-3"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108906"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S400458"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02059-5"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14090873"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S104807"},{"key":"e_1_2_11_32_1","unstructured":"\u201cGlobal Manual on Surveillance of Adverse Events Following Immunization \u201d World Health Organization 2014 revised March 2016 https:\/\/www.who.int\/publications\/i\/item\/9789241507769."},{"key":"e_1_2_11_33_1","unstructured":"\u201cCausality Assessment of an Adverse Event Following Immunization (\u200eAEFI)\u200e: User Manual for the Revised WHO Classification 2nd ed. \u201d WHO 2019 https:\/\/www.who.int\/publications\/i\/item\/9789241516990."},{"key":"e_1_2_11_34_1","unstructured":"\u201cCommon Terminology Criteria for Adverse Events (CTCAE) Version 5.0 \u201d Dep. Heal. Hum. Serv. Natl. Institutes Heal. Natl. Cancer Institute accessed September 1 2024 https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf."},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109784"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmy130"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.04.032"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00511-5"},{"key":"e_1_2_11_40_1","unstructured":"\u201cInternational Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use \u201d MedDRA: Medical Dictionary for Regulatory Activities accessed September 1 2024 https:\/\/www.ich.org\/page\/meddra."},{"key":"e_1_2_11_41_1","unstructured":"\u201cSNOMED CT Clinical Terminology \u201d SNOMED International accessed September 1 2024 https:\/\/www.snomed.org\/."},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17982"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-152118"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.05.011"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/ijph.2023.1605526"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54886-0"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00078-8"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0296669"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_176_23"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020231"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2323853"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1348015"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.22207\/JPAM.17.2.21"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.4103\/bbrj.bbrj_9_23"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035549"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47670"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2023.69"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010105"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11050892"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.18502\/ijm.v15i2.12467"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54450-w"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08103-4"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-023-03432-8"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050522"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0124-6"}],"container-title":["Health Science Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.70492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T13:22:00Z","timestamp":1743340920000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hsr2.70492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1002\/hsr2.70492"],"URL":"https:\/\/doi.org\/10.1002\/hsr2.70492","archive":["Portico"],"relation":{},"ISSN":["2398-8835","2398-8835"],"issn-type":[{"type":"print","value":"2398-8835"},{"type":"electronic","value":"2398-8835"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2023-12-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70492"}}